Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03681288 · ClinicalTrials.gov registry record · NA

Mindful Self Compassion for Combat Deployed Veterans With Moral Injury and Co-occurring PTSD-SUD

A NA study of Post Traumatic Stress Disorder and Substance Use Disorder, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
34
Enrollment target
1
Study location

NCT03681288 is a NA study of Post Traumatic Stress Disorder and Substance Use Disorder that has completed, run by VA Office of Research and Development. The registered enrollment target is 34 participants, below the 1,117-participant average among 144 other Post Traumatic Stress Disorder trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03681288, a NA study of Post Traumatic Stress Disorder and Substance Use Disorder, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target
1
Study location

Study Summary

Veterans with co-occurring Posttraumatic Stress Disorder and Substance Use Disorder (PTSD-SUD) experience more severe symptomatology and poorer response to existing treatments than Veterans with either disorder alone. Guilt is a common posttraumatic reaction and has been implicated as a risk factor for the development and maintenance of PTSD and substance use. Combat Veterans often report experiencing moral injury defined as perpetrating, failing to prevent, or witnessing acts that violate the values they live by in their civilian lives, which can lead to feelings of guilt and shame. Accordingly, reduction in guilt and increase in self-compassion may lead to improved quality of life for Veterans. This project will conduct a pilot study to evaluate changes in self-compassion, guilt, and PTSD-SUD symptom severity in a sample of Veterans after receiving 8 sessions of Mindful Self Compassion treatment (via a telehealth modality during COVID-19 pandemic). Findings will have significant impact on effective treatment options and lead to improvements in Veterans' quality of life and posttraumatic symptoms.

Conditions Studied

Post Traumatic Stress Disorder Substance Use Disorder Moral Injury

Interventions

  • BEHAVIORAL Mindful Self-Compassion

Study Locations (1)

Rhode Island

  • Providence VA Medical Center, Providence, RI - Providence

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2019-07-08
Est. Completion 2021-03-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03681288

The ClinicalTrials.gov registry entry for NCT03681288 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,117-participant average among 144 other Post Traumatic Stress Disorder trials with a reported enrollment target (97% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which Mindful Self-Compassion is the first listed.

NCT03681288 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT03681288 about?

NCT03681288 is a clinical study titled "Mindful Self Compassion for Combat Deployed Veterans With Moral Injury and Co-occurring PTSD-SUD". Veterans with co-occurring Posttraumatic Stress Disorder and Substance Use Disorder (PTSD-SUD) experience more severe symptomatology and poorer response to existing treatments than Veterans with either disorder alone. Guilt is a common posttraumatic reaction and has been implicated as a risk factor ...

What is the current status of trial NCT03681288?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2019-07-08. Estimated completion is 2021-03-31.

What conditions does trial NCT03681288 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Substance Use Disorder, Moral Injury.

What interventions are being tested in trial NCT03681288?

The interventions under investigation include: Mindful Self-Compassion (BEHAVIORAL).

Who is sponsoring clinical trial NCT03681288?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03681288 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Post Traumatic Stress Disorder

All registered trials for this condition

Substance Use Disorder

All registered trials for this condition

Rhode Island

All trials with a study site in Rhode Island

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.